Combination therapy using Cel-CSO/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K/AKT/NF-κB/HIF-1α pathway
使用 Cel-CSO/Taxol NPs 进行联合治疗通过抑制 PI3K/AKT/NF-κB/HIF-1α 通路逆转乳腺癌耐药性
期刊:Drug Delivery and Translational Research
影响因子:5.7
doi:10.1007/s13346-024-01653-3
Huahui Zeng, Xiaohu Zeng, Can Wang, Guoqiang Wang, Qikang Tian, Junwei Zhao, Lingzhou Zhao, Ruiqin Li, Ying Luo, Haotian Peng, Zhenqiang Zhang, Xiaofang Li, Xiangxiang Wu